Medvi reviews have been surging in search over the past month, largely because it’s one of the cheapest ways to access compounded GLP-1 medications like semaglutide and tirzepatide without insurance. But “cheap” and “legit” aren’t the same question, and this niche has no shortage of platforms that blur that line. Here’s what’s actually verifiable about Medvi, based on public records, regulatory information, and patterns across independent customer reviews — not the company’s own marketing.
What Is Medvi?
Medvi (also seen as MEDVi, medvi.org, or under the name CareGLP) is a telehealth weight loss platform that connects patients with licensed clinicians for prescriptions of compounded semaglutide and tirzepatide, along with access to brand-name Wegovy and Zepbound through a membership model. Like most platforms in this space, the process works roughly the same way: complete an online health evaluation, get matched with a state-licensed prescriber, and receive medication by mail from a partner pharmacy if approved.
Is Medvi Legit? The Straight Answer
Yes, in the regulatory sense — Medvi is a real, operating telehealth business, not a scam that disappears with your payment. It works with state-licensed prescribing clinicians and partner compounding pharmacies, and it has a documented corporate presence.
That said, “legitimate business” doesn’t mean “flawless” or “risk-free,” and there’s one fact worth taking seriously: Medvi received an FDA warning letter in February 2026 over misleading claims on its website. That’s a meaningful red flag specifically about how the company markets itself, separate from whether the underlying medications work.
The more useful question isn’t “is Medvi a scam,” it’s: does the specific version of the service you’d be paying for match what you need, at a price and risk level you’re comfortable with?
What Real Customers Actually Say
Reviews of Medvi are genuinely split, and the split follows a pattern:
Common positive themes:
- Faster approval process than many competitors
- Lower first-month pricing than several other telehealth GLP-1 providers
- HSA/FSA payment accepted
- Some users report meaningful weight loss results, consistent with what compounded tirzepatide and semaglutide can do when dosed correctly
Common complaints:
- Billing issues, including being charged for months after attempting to cancel
- Slow or difficult refund processes
- A few reports of temperature-sensitive medication arriving improperly packaged
- Inconsistent results — some users report little to no weight loss despite months of use, which can happen with underdosing or individual response variation
This mixed picture is common across the entire compounded GLP-1 telehealth category, not unique to Medvi — but the volume and consistency of billing-related complaints specifically is worth factoring into your decision.
Compounded vs. Brand-Name: What You’re Actually Buying
This is the detail most comparison articles gloss over, and it matters more than the price difference.
- Brand-name GLP-1 drugs (Wegovy, Zepbound, Ozempic, Mounjaro) go through FDA approval for safety, effectiveness, and manufacturing quality.
- Compounded versions of semaglutide or tirzepatide use the same active ingredient but are prepared by compounding pharmacies under a different regulatory pathway. They are not FDA-approved as finished products, meaning the agency hasn’t independently verified their safety, effectiveness, or consistency batch to batch.
Compounding itself is legal and has legitimate medical uses, including when brand-name drugs are in shortage. But it does shift more of the quality-assurance burden onto the individual pharmacy and provider network — which is why checking which pharmacy a platform actually uses matters more than the marketing page does.
How Medvi’s Pricing Works
Medvi generally advertises a lower first-month rate for compounded semaglutide or tirzepatide, with pricing that increases at higher doses or after the introductory period. Brand-name Wegovy/Zepbound access is typically offered through a separate membership fee plus the cost of medication. Exact current pricing changes frequently in this space, so always confirm current numbers directly on the platform before committing, rather than relying on any article — including this one — for exact figures.
Who Might Consider Medvi (and Who Shouldn’t)
Might be worth exploring:
- People without insurance coverage for GLP-1 medications who are comparing telehealth options on price
- People comfortable with compounded medications and doing their own due diligence on the pharmacy involved
Should think twice or look elsewhere:
- Anyone uncomfortable with the regulatory gray area around compounded (non-FDA-approved) formulations — this is also a good reason to look into our best GLP-1 supplement guide for a non-prescription starting point instead
- Anyone who has read multiple recent billing complaints and isn’t willing to closely monitor their card statements and cancellation confirmations
- Anyone with underlying health conditions who needs closer in-person medical supervision than an async telehealth model provides
How to Evaluate Any Telehealth GLP-1 Provider (Medvi Included)
- Ask which specific pharmacy compounds your medication, and verify it’s state-licensed (503A or 503B).
- Read the cancellation policy before signing up, not after — this is where most complaints across this entire industry originate.
- Check recent regulatory history, including FDA warning letters, not just star ratings.
- Compare the total cost at 3 and 6 months, not just the first-month promotional price.
- Confirm what happens if the medication doesn’t work for you — refund policy, dose adjustment process, and how quickly you can reach a provider.
FAQ
Is Medvi legit?
Medvi is a real, operating telehealth company with licensed clinicians and pharmacy partners — it is not a scam in the sense of taking money with no service provided. However, it received an FDA warning letter in February 2026 over misleading marketing claims, and customer reviews show a notable pattern of billing and refund complaints.
Is Medvi FDA-approved?
No compounded medication platform is “FDA-approved” in the way brand-name drugs are. Medvi’s compounded semaglutide and tirzepatide use FDA-approved active ingredients, but the compounded end product itself does not go through FDA review for safety, effectiveness, or manufacturing consistency.
How much does Medvi cost?
Pricing varies by medication, dose, and current promotions, generally starting with a lower introductory rate for compounded GLP-1s. Confirm current pricing directly on Medvi’s official site, since telehealth pricing in this space changes frequently.
Is Medvi better than other GLP-1 telehealth platforms?
It depends on what you’re optimizing for. Medvi tends to compete on price and speed of approval; other platforms differentiate on flat-rate pricing, brand-name-only access, or more consistent customer service ratings — see how it stacks up against our Embody GLP-1 review if you’re weighing both. Compare cancellation policies and pharmacy partners directly, not just price.
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications, compounded or brand-name, should only be used under the guidance of a licensed healthcare provider. Always verify current pricing, regulatory status, and pharmacy partners directly with any telehealth provider before enrolling.